Voyant Fine Fusion Device EB230
510(k) K202818
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK202818 | Date16 Dec 2021 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GEI
- Device Class
- Class II
- Regulation
- 21 CFR Part 878.4400
- Advisory Committee
- General, Plastic Surgery
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
The Voyant Fine Fusion Device is an electrosurgical instrument designed to seal vessels up to 7mm in diameter and tissue bundles. It delivers radio-frequency energy to tissue captured between its jaws and features a user-actuated blade to divide the sealed tissue.
This device is intended for use in open procedures, including head and neck surgeries where working space is limited and finer jaws are required. It is identified by model number EB230 and has received FDA 510k clearance.
Other devices from Applied Medical
Questions
AI-generated answers, 24 Sep 2026
What is the primary clinical use of the Voyant Fine Fusion Device?
The Voyant Fine Fusion Device is designed for use in open surgical procedures to seal vessels up to 7mm in diameter and tissue bundles. Its finer jaw design makes it particularly suitable for head and neck surgeries where the surgical working space is limited.
How does the device function during surgery?
The instrument delivers radio-frequency energy to tissue captured between its jaws to create a seal. Once the seal is established, the device features a user-actuated blade that allows the surgeon to divide the sealed tissue.
What is the regulatory status of the Voyant Fine Fusion Device?
The Voyant Fine Fusion Device (EB230) has received FDA 510k clearance. This indicates that the device has been reviewed and found to be substantially equivalent to legally marketed predicate devices.